<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Vasc Health Risk Manag</journal-id>
      <journal-id journal-id-type="iso-abbrev">Vasc Health Risk Manag</journal-id>
      <journal-id journal-id-type="publisher-id">Vascular Health and Risk Management</journal-id>
      <journal-title-group>
        <journal-title>Vascular Health and Risk Management</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1176-6344</issn>
      <issn pub-type="epub">1178-2048</issn>
      <publisher>
        <publisher-name>Dove Medical Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25061314</article-id>
      <article-id pub-id-type="pmc">4085334</article-id>
      <article-id pub-id-type="doi">10.2147/VHRM.S64286</article-id>
      <article-id pub-id-type="publisher-id">vhrm-10-399</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Cardiac angiosarcoma: utility of [<sup>18</sup>F]fluorodeoxyglucose positron emission tomography&#x2013;computed tomography in evaluation of residue, metastases, and treatment response</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Tokmak</surname>
            <given-names>Handan</given-names>
          </name>
          <xref ref-type="aff" rid="af1-vhrm-10-399">1</xref>
          <xref ref-type="corresp" rid="c1-vhrm-10-399"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Demir</surname>
            <given-names>Nurhan</given-names>
          </name>
          <xref ref-type="aff" rid="af2-vhrm-10-399">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Demirkol</surname>
            <given-names>Mehmet Onur</given-names>
          </name>
          <xref ref-type="aff" rid="af3-vhrm-10-399">3</xref>
        </contrib>
      </contrib-group>
      <aff id="af1-vhrm-10-399"><label>1</label>Department of Nuclear Medicine and Molecular Imaging, American Hospital, Ni&#x15F;anta&#x15F;i, Istanbul, Turkey</aff>
      <aff id="af2-vhrm-10-399"><label>2</label>Internal Medicine Department, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey</aff>
      <aff id="af3-vhrm-10-399"><label>3</label>Department of Nuclear Medicine and Molecular Imaging, Ko&#xE7; University, Istanbul, Turkey</aff>
      <author-notes>
        <corresp id="c1-vhrm-10-399">Correspondence: Handan Tokmak, Department of Nuclear Medicine and Molecular Imaging, American Hospital, 20 G&#xFC;zelbah&#xE7;e Sokak, Ni&#x15F;anta&#x15F;i, Istanbul 34365, Turkey, Tel +90 212 444 3777 ext 2586, Fax +90 212 311 2190, Email <email>handantokmak@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>27</day>
        <month>6</month>
        <year>2014</year>
      </pub-date>
      <volume>10</volume>
      <fpage>399</fpage>
      <lpage>401</lpage>
      <permissions>
        <copyright-statement>&#xA9; 2014 Tokmak et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution &#x2013; Non Commercial (unported, v3.0) License</copyright-statement>
        <copyright-year>2014</copyright-year>
        <license>
          <license-p>The full terms of the License are available at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Cardiac angiosarcomas are a rare form of malignancy. The majority of cases arise from the right atrium as mural masses. These tumors have extremely aggressive behavior, with early clinical symptoms that vary depending on location, size, and extent of the tumor. Most of these patients have a very short survival time. Surgical therapy is considered the best choice of therapy approach in cardiac angiosarcoma patients with nonmetastatic disease, even though the disease is rarely cured. Advanced diagnostic techniques facilitate accurate, noninvasive assessments of cardiac sarcomas. We report a case of a 62-year-old man with cardiac angiosarcoma who had multiple distant metastases that were revealed by [<sup>18</sup>F]fluorodeoxyglucose positron emission tomography&#x2013;computed tomography imaging.</p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>primary cardiac angiosarcoma</kwd>
        <kwd>FDG PET/CT imaging</kwd>
        <kwd>noninvasive assessment of cardiac sarcomas</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>Sarcoma is the most common primary malignancy of the heart and pericardium. Primary cardiac sarcomas are rare entities,<xref rid="b1-vhrm-10-399" ref-type="bibr">1</xref>&#x2013;<xref rid="b3-vhrm-10-399" ref-type="bibr">3</xref> with an autopsy prevalence of 0.001%&#x2013;0.28%.<xref rid="b3-vhrm-10-399" ref-type="bibr">3</xref> Pathologic subtypes of primary cardiac sarcoma are angiosarcoma fibrosarcoma, rhabdomyosarcoma, malignant schwannoma, and mesothelioma. Frequency rate decreases in adults.</p>
      <p>Angiosarcoma frequency is less than 1% among sarcomas. Of all angiosarcomas, a primary angiosarcoma of the heart and the great vessels accounts for only 3%.<xref rid="b4-vhrm-10-399" ref-type="bibr">4</xref> Most of cardiac angiosarcomas (80%) originate from right atrium as mural masses. Extension to the pericardium and encasement of the heart may be seen, and usually fills the entire cardiac chamber. The aggressive behavior of cardiac angiosarcomas causes early symptoms and a very short survival rate. Clinical presentation of sarcomas varies depending on the location, size, and extent of the tumor. Advanced diagnostic techniques facilitate accurate, noninvasive assessment of cardiac sarcomas.<xref rid="b5-vhrm-10-399" ref-type="bibr">5</xref></p>
      <p>Diagnostic workup usually includes standard echo contrast-enhanced computed tomography (CT), magnetic resonance imaging, and angiography. In the literature, a few case reports have demonstrated the diagnostic contribution of [<sup>18</sup>F]fluorodeoxyglucose (FDG) positron emission tomography (PET)-CT in the evaluation of the malignant nature of disease and staging before deciding on the therapy aproach.<xref rid="b6-vhrm-10-399" ref-type="bibr">6</xref>,<xref rid="b7-vhrm-10-399" ref-type="bibr">7</xref></p>
      <p>Even though cardiac angiosarcoma is rarely cured, surgical therapy is considered the best choice of therapy in nonmetastatic disease.<xref rid="b8-vhrm-10-399" ref-type="bibr">8</xref> Complete or partial surgical resection of primary or metastatic cardiac sarcoma can provide significant hemodynamic improvement, successful palliation, and prolonged survival.<xref rid="b9-vhrm-10-399" ref-type="bibr">9</xref>,<xref rid="b10-vhrm-10-399" ref-type="bibr">10</xref> Chemotherapy and postsurgical adjuvant radiotherapy have not proven consistently beneficial. However, all treatment choices after surgical resection can ameliorate symptoms with a varied response.<xref rid="b11-vhrm-10-399" ref-type="bibr">11</xref></p>
    </sec>
    <sec>
      <title>Case report</title>
      <p>Herein, we report the case of a 62-year-old man who had previously undergone tumor resection for primary high-grade cardiac angiosarcoma (<xref ref-type="fig" rid="f1-vhrm-10-399">Figure 1</xref>) at a university hospital 4 months previously. The patient was referred to the Nuclear Medicine Department for <sup>18</sup>F-FDG PET-CT imaging to assess residual and/or metastatic disease.</p>
      <p>The tumor was surgically approached by medial sternotomy, but complete tumor resection was not possible because of the extensive tumor infiltration. Palliative intervention consisting of partial excision of the tumor mass was aimed at releasing the right ventricular outflow tract.</p>
      <p>PET-CT scans revealed a residual or relapsed mass in the right atrium, with significantly increased uptake of <sup>18</sup>F-FDG (maximum standardized uptake value of 12). The mass extended to the mitral valve, septum, and left ventricle and infiltrated to the pericardium and adjacent mediastinum (<xref ref-type="fig" rid="f2-vhrm-10-399">Figure 2</xref>). The mass encased and almost completely replaced the atrial wall and nearly filled the entire cardiac chamber. Increased activity in the sternum was concomitant with sternotomy. PET-CT images also revealed multiple distant metastasis in the lung, liver, and bones (<xref ref-type="fig" rid="f3-vhrm-10-399">Figure 3</xref>). Despite receiving subsequent aggressive therapy, including radiotherapy, the patient died 8 months later.</p>
    </sec>
    <sec>
      <title>Conclusion</title>
      <p>Angiosarcoma is a very aggressive malignant neoplasm with a short fatal clinical process, despite new, cutting edge, treatment modalities, such as extensive surgery, radiotherapy, and chemotherapy.<xref rid="b12-vhrm-10-399" ref-type="bibr">12</xref> Nowadays, through advanced diagnostic technology, such as high-resolution CT, dynamic magnetic resonance imaging, and PET-CT, clinicians are able to diagnose in a shorter time, which allows for more effective radical surgical resection. <sup>18</sup>F-FDG PET-CT seems to be an effective and feasible imaging modality to evaluate primary or postsurgical residue and/or relapse and metastases of the tumor.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn>
        <p>
          <bold>Disclosure</bold>
        </p>
        <p>The authors report no conflicts of interest in this work.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="b1-vhrm-10-399">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reynen</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Frequency of primary tumors of the heart</article-title>
          <source>Am J Cardiol</source>
          <year>1996</year>
          <volume>77</volume>
          <fpage>107</fpage>
          <pub-id pub-id-type="pmid">8540447</pub-id>
        </element-citation>
      </ref>
      <ref id="b2-vhrm-10-399">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Silverman</surname>
              <given-names>NA</given-names>
            </name>
          </person-group>
          <article-title>Primary cardiac tumors</article-title>
          <source>Ann Surg</source>
          <year>1980</year>
          <volume>191</volume>
          <fpage>127</fpage>
          <lpage>138</lpage>
          <pub-id pub-id-type="pmid">7362282</pub-id>
        </element-citation>
      </ref>
      <ref id="b3-vhrm-10-399">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barreiro</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Renilla</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Jimenez</surname>
              <given-names>JM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Primary cardiac tumors: 32 years of experience from a Spanish tertiary surgical center</article-title>
          <source>Cardiovasc Pathol</source>
          <year>2013</year>
          <volume>22</volume>
          <fpage>424</fpage>
          <lpage>427</lpage>
          <pub-id pub-id-type="pmid">23727543</pub-id>
        </element-citation>
      </ref>
      <ref id="b4-vhrm-10-399">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lantz</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Dougherty</surname>
              <given-names>TH</given-names>
            </name>
            <name>
              <surname>Lucca</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Primary angiosarcoma of the heart causing cardiac rupture</article-title>
          <source>Am Heart J</source>
          <year>1989</year>
          <volume>118</volume>
          <fpage>186</fpage>
          <lpage>188</lpage>
          <pub-id pub-id-type="pmid">2741790</pub-id>
        </element-citation>
      </ref>
      <ref id="b5-vhrm-10-399">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yuan</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Shinfeld</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lavee</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kuperstein</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Haizler</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Raanani</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Imaging morphology of cardiac tumours</article-title>
          <source>Cardiol J</source>
          <year>2009</year>
          <volume>16</volume>
          <fpage>26</fpage>
          <lpage>35</lpage>
          <pub-id pub-id-type="pmid">19130413</pub-id>
        </element-citation>
      </ref>
      <ref id="b6-vhrm-10-399">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hori</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Funabashi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Miyauchi</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Angiosarcoma in the right atria demonstrated by fusion images of multislice computed tomography and positron emission tomography using F-18 fluoro-deoxyglucose</article-title>
          <source>Int J Cardiol</source>
          <year>2007</year>
          <volume>123</volume>
          <fpage>e15</fpage>
          <lpage>e17</lpage>
          <pub-id pub-id-type="pmid">17316847</pub-id>
        </element-citation>
      </ref>
      <ref id="b7-vhrm-10-399">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Higashiyama</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kawabe</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hayashi</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Effectiveness of preoperative PET examination of huge angiosarcoma of the heart</article-title>
          <source>Clin Nucl Med</source>
          <year>2009</year>
          <volume>34</volume>
          <fpage>99</fpage>
          <lpage>102</lpage>
          <pub-id pub-id-type="pmid">19352263</pub-id>
        </element-citation>
      </ref>
      <ref id="b8-vhrm-10-399">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Truong</surname>
              <given-names>PT</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>SO</given-names>
            </name>
            <name>
              <surname>Martens</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Treatment and outcomes in adult patients with primary cardiac sarcoma: the British Columbia Cancer Agency experience</article-title>
          <source>Ann Surg Oncol</source>
          <year>2009</year>
          <volume>16</volume>
          <fpage>3358</fpage>
          <lpage>3365</lpage>
          <pub-id pub-id-type="pmid">19830494</pub-id>
        </element-citation>
      </ref>
      <ref id="b9-vhrm-10-399">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reardon</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Walkes</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Benjamin</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Therapy insight: malignant primary cardiac tumors</article-title>
          <source>Nat Clin Pract Cardiovasc Med</source>
          <year>2006</year>
          <volume>3</volume>
          <fpage>548</fpage>
          <lpage>553</lpage>
          <pub-id pub-id-type="pmid">16990840</pub-id>
        </element-citation>
      </ref>
      <ref id="b10-vhrm-10-399">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Furukawa</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Gummert</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>B&#xF6;rgermann</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Complete resection of undifferentiated cardiac sarcoma and reconstruction of the atria and the superior vena cava: case report</article-title>
          <source>J Cardiothorac Surg</source>
          <year>2012</year>
          <volume>7</volume>
          <fpage>96</fpage>
          <pub-id pub-id-type="pmid">23013671</pub-id>
        </element-citation>
      </ref>
      <ref id="b11-vhrm-10-399">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kakizaki</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Takagi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hosaka</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Cardiac angiosarcoma responding to multidisciplinary treatment</article-title>
          <source>Int J Cardiol</source>
          <year>1997</year>
          <volume>62</volume>
          <fpage>273</fpage>
          <lpage>275</lpage>
          <pub-id pub-id-type="pmid">9476688</pub-id>
        </element-citation>
      </ref>
      <ref id="b12-vhrm-10-399">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Look Hong</surname>
              <given-names>NJ</given-names>
            </name>
            <name>
              <surname>Pandalai</surname>
              <given-names>PK</given-names>
            </name>
            <name>
              <surname>Hornick</surname>
              <given-names>JL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cardiac angiosarcoma management and outcomes: 20-year single-institution experience</article-title>
          <source>Ann Surg Oncol</source>
          <year>2012</year>
          <volume>19</volume>
          <issue>8</issue>
          <fpage>2707</fpage>
          <lpage>2715</lpage>
          <pub-id pub-id-type="pmid">22476752</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="f1-vhrm-10-399" position="float">
      <label>Figure 1</label>
      <caption>
        <p>Histopathology findings.</p>
      </caption>
      <graphic xlink:href="vhrm-10-399Fig1"/>
    </fig>
    <fig id="f2-vhrm-10-399" position="float">
      <label>Figure 2</label>
      <caption>
        <p><sup>18</sup>F-FDG PET-CT image showing the tumor mass in the right atrium.</p>
        <p><bold>Abbreviations:</bold> CT, computed tomography; FDG, fluorodeoxyglucose; PET, positron emission tomography.</p>
      </caption>
      <graphic xlink:href="vhrm-10-399Fig2"/>
    </fig>
    <fig id="f3-vhrm-10-399" position="float">
      <label>Figure 3</label>
      <caption>
        <p>Maximum intensity projection image <sup>18</sup>F-FDG PET-CT shows multiple distant metastasis in the lung, liver and bones.</p>
        <p><bold>Abbreviations:</bold> CT, computed tomography; FDG, fluorodeoxyglucose; PET, positron emission tomography; dm, mean decimeter.</p>
      </caption>
      <graphic xlink:href="vhrm-10-399Fig3"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
